StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.52−0.01 (-1.67%)

Close on Nov 17, 2026Market cap $14.24MP/E –Yield –

Citius Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Citius Pharmaceuticals's market cap was $13.19M on Nov 11, 2026, against $26.02M a year earlier. Over the last 5 years it ranged from $5.91M to $261.39M, with a median of $108.72M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$13.19M-6.0%
2025Dec 31, 2025$14.04M-51.6%
2024Dec 31, 2024$28.99M-75.9%
2023Dec 29, 2023$120.18M+4.0%
2022Dec 30, 2022$115.51M-48.6%
2021Dec 31, 2021$224.81M+296.6%
2020Dec 31, 2020$56.69M+92.1%
2019Dec 31, 2019$29.51M+75.2%
2018Dec 31, 2018$16.85M-46.9%
2017Dec 29, 2017$31.71M-2.3%
2016Dec 30, 2016$32.47M-2.5%
2015Dec 31, 2015$33.30M+77.9%
2014Dec 31, 2014$18.72M–

More Citius Pharmaceuticals figures

See a number that looks wrong?